Decitabine (Sandoz Inc)
Welcome to the PulseAid listing for the Decitabine drug offered from Sandoz Inc. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sandoz Inc |
| NON-PROPRIETARY NAME: | Decitabine |
| SUBSTANCE NAME: | DECITABINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2014-08-28 |
| END MARKETING DATE: | 0000-00-00 |
Decitabine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Decitabine from Sandoz Inc |
| LABELER NAME: | Sandoz Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/50mL) |
| START MARKETING DATE: | 2014-08-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0781-3139_0b9599e8-9018-42ee-b247-e2a944c36510 |
| PRODUCT NDC: | 0781-3139 |
| APPLICATION NUMBER: | ANDA202969 |
Other DECITABINE Pharmaceutical Manufacturers / Labelers:
